The findings were similar in patients with osteopenia (r = 0.631, Fig. 3c) and osteoporosis (r = 0.682, Fig. 3d), which suggested that IL-20 may be involved in osteoblastogenesis by regulating sclerostin, and associated with metabolic bone diseases. Here, SOST is linked to Osteopenia.